Rigorous research in the field of probiotics is a fairly new phenomenon although first reports about beneficial effects of specific gut bacteria on human health originated already a century ago. A prerequisite for such a scrutiny has been a definition of criteria for probiotics. Recently, novel molecular technologies have characterized both potential targets of probiotic action, like gut microbiota and established and candidate probiotic strains in more detail. We thus propose here revised criteria for selection of probiotics. In addition to several promising clinical studies e.g., in the prevention and treatment of atopic eczema, certain probiotics have been found to maintain intestinal equilibrium by enhancing the gut mucosal barrier via manipulation of expression of several their own and the host’s genes. Introduction of genetic engineering has provided advanced tools to amend probiotics’ properties in the fight against different inflammatory conditions.
- Atopic Eczema
- Intestinal Epithelial Cell
- Allergy Clin Immunol
- Probiotic Bacterium
- Probiotic Strain
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Tax calculation will be finalised at checkout
Purchases are for personal use onlyLearn about institutional subscriptions
Unable to display preview. Download preview PDF.
Tissier H. Traitment de infections intestinales par la methode de la flore bacterienne de I’intestin. C R Soc Biol 1906; 60:359–361.
Metchnikoff E. The Prolongation of Life: Optimistic Studies. London: Heinemann, 1907.
Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science 1965; 47:747–748.
Szajewska H, Setty M, Mrukowicz J et al. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficicacy. J Pediatr Gastroenterol Nutr 2006; 42:454–475.
Floch MH, Montrose DC. Use of probiotics in humans: an analysis of the literature. Gastroenterol Clin N Am 2005; 34:547–570.
Snelling AM. Effects of probiotics on the gastrointestinal tract. Curr Opin Infect Dis 2005; 18:420–426.
Salminen S, Bouley MC, Boutron-Rualt MC et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; Suppl 1:147–171.
Diplock A, Aggett P, Ashwell M et al. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr 1999; 8(Suppl 1):1–27.
Mogensen G, Salminen S, O’Brien J et al. Food Microorganisms-health benefits, safety evaluation and strains with documented history of use in foods. IDF Bulletin 2002; 377:4–9.
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 381:512–519.
Kalliomäki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial with probiotics. Lancet 2001; 357:1076–1079.
Junctunen M, Kirjavainen P, Ouwehand AC et al. Gut microflora changes and probiotics in children in day care centers. Bioscience and Microflora 2003; 22:99–107.
Lick S, Drescher K, Heller KJ. Survival of Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in the terminal ileum of fistulated Gottingen minipigs. Appl Environ Microbiol. 2001; 67:4137–4143.
Mater DD, Bretigny L, Firmesse O et al. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol Lett 2005; 250:185–187.
Breeuwer P, Abee T. Assessment of viability of microorganisms employing fluorescence technique. Int J Food Microbiol 2000; 55:193–200.
Bunthof CJ, Abee T. Development of a flow cytometric method to analyze subpopulations of bacteria in probiotic products and dairy starters. Appl Environ Microbiol 2002; 68:2934–2942.
Amor KB, Breeuwer P, Verbaarschot P et al. Multiparametric flow cytometry and cell sorting for the assessment of viable, injured and dead bifidobacterium cells during bile salt stress. Appl Environ Microbiol 2002; 68:5209–5216.
Lahtinen SJ, Gueimonde M, Ouwehand AC et al. Probiotic bacteria may become dormant during storage. Appl Environ Microbiol 2005; 71:1662–1663.
Vaughan EE, Heilig HG, Ben-Amor K et al. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 2005; 29:477–490.
Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 1993; 104:622–639.
Isolauri E, Kaila M, Arvola T et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993; 33:548–553.
Isolauri E, Majamaa H, Arvola T et al. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105:1643–1650.
Rosenfeldt V, Benfeldt E, Valerius NH et al. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145:612–616.
Liévin-Le Moal V, Amsellem R, Servin AL et al. Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 2002; 50:803–811.
Boudeau J, Glasser AL, Julien S et al. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn’s disease. Aliment Pharmacol Ther 2003; 18:45–56.
Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52:988–997.
Mack DR, Michail S, Wei S et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276:G941–950.
Mack DR, Ahrne S, Hyde L et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52: 827–833.
Wehkamp J, Harder J, Wehkamp K et al. NF-κB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Inf Immunol 2004; 72:5750–5758.
Otte J-M, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286:G613–626.
Brandtzaeg P. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 1995; 103:1–19.
Kaila M, Isolauri E, Soppi E et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32:141–144.
Viljanen M, Kuitunen M, Haahtela T et al. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005; 16:65–71.
Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Inf Immunol 2004; 72:5308–14.
Tien M-T, Girardin SE, Regnault B et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006; 176:1228–1237.
Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959–65.
Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha-and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006; 130:731–46.
Holgate ST. The epidemic of allergy and asthma. Nature 1999; 402(6760 Suppl):B2–4.
Stock P, DeKruyff FH, Umetsu DT. Inhibition of the allergic response by regulatory T-cells. Curr Opin Allergy Clin Immunol 2006; 6:12–16.
Prescott SL, Macaubas C, Holt BJ et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses toward the Th2 cytokine profile. J Immunol 1998; 160:4730–4737.
Prescott SL, Macaubes C, Smallacombe T et al. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353:196–200.
Piccinni MP, Beloni L, Livi C et al. Defective production of both leukaemia inhibitory factor and type 2 T helper cytokines by decidual T-cells in unexplained recurrent abortions. Nat Med 1998; 4(9):1020–1024.
Rautava S, Kalliomäki M, Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics—A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 2005; 116:31–37.
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants epidermal junction protein filagrin are a major disposing factor for atopic dermatitis. Nat Genet 2006; 38:441–446.
Boguniewicz M, Leung DY. Atopic dermatitis. J Allergy Clin Immunol 2006; 177: S475–480.
Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol, 1996:985–990.
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179–85.
Isolauri E, Arvola T, Sütas Y et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604–10.
Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111:389–395.
Weston S, Halbert A, Richmond P et al. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch Dis Child 2005; 90:892–897.
Viljanen M, Savilahti E, Haahtela T et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60:494–500.
Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36:223–227.
Kalliomäki M, Salminen S, Poussa T et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869–1871.
Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119–121.
Rinne M, Kalliomäki M, Salminen S et al. Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. J Pediatr Gastroenterol Nutr 2006; 43:200–205.
Laitinen K, Kalliomäki M, Poussa T et al. Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. Br J Nutr 2005; 94:565–574.
Rinne M, Kalliomäki M, Arvilommi H et al. Effect of probiotics and breastfeeding on the Bifidobacterium and Lactobacillus/Enterococcus microbiota and humoral immune responses. J Pediatr 2005; 147:186–191.
Laitinen K, Isolauri E. Management of food allergy: vitamins, fatty acids or probiotics? Eur J Gastroenterol Hepatol 2005; 17:1305–1311.
Zoetendal EG, Vaughan EE, De Vos WM. A microbial world within us. Mol Microbiol 2006; 59:1639–1650.
Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 2006; 17:204–210.
Bron PA, Molenaar D, de Vos WM et al. DNA microarray-based identification of bile-responsive genes in Lactobacillus plantarum. J Appl Microbiol 2006; 100:728–738.
Azcarate-Peril MA, McAuliffe O, Altermann E et al. Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus. Appl Environ Microbiol 2005; 71:5794–5804.
Bron PA, Grangette C, Mercenier A et al. Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol 2004; 186:5721–5729.
De Vries MC. Analyzing global gene expression of Lactobacillus plantarum in the human gastro-intestinal tract. Thesis, Wageningen University, Wagneingen, the Netherlands, 2006.
Di Caro S, Tao H, Grillo A et al. Effects of Lactobacillus GG on gene expression pattern in small bowel mucosa. Dig Liver Dis 2005; 37:320–329.
Di Caro S, Tao H, Grillo A et al. Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol 2005; 17-951-60.
De Vos WM, Castenmiller JJM, Hamer RJ et al. Nutridynamics—studying the dynamics of food components in products and in the consumer. Curr Opin Biotechnol 2006; 17:217–225.
Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactobacillus lactis secreting interleukin-10. Science 2000; 289:1352–1355.
Steidler L, Neirynck S, Huyghebaert N et al. Biological containment of genetically modified Lactobacillus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003; 21:785–789.
Huyghebaert N, Vermeire A, Neirynck S et al. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. Eur J Pharm Biopharm 2005; 60:349–359.
Vandenbroucke K, Hans W, Van Huysse J et al. Active delivery of trefoil factors by genetically modified Lactobacillus lactis prevents and heals acute colitis in mice. Gastroenterology 2004; 127:502–513.
Grangette C, Nutten S, Palumbo E et al. Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Nat Acad Sci 2005; 102:10321–10326.
Editors and Affiliations
© 2008 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Kalliomäki, M., Salminen, S., Isolauri, E. (2008). Positive Interactions with the Microbiota: Probiotics. In: Huffnagle, G.B., Noverr, M.C. (eds) GI Microbiota and Regulation of the Immune System. Advances in Experimental Medicine and Biology, vol 635. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09550-9_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79989-6
Online ISBN: 978-0-387-09550-9